Arch Biopartners (TSXV:ARCH) Preferred Dividends : C$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Arch Biopartners's preferred dividends for the three months ended in Dec. 2024 was C$0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

Arch Biopartners Preferred Dividends Historical Data

The historical data trend for Arch Biopartners's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Preferred Dividends Chart

Arch Biopartners Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Preferred Dividends

Get a 7-Day Free Trial

Arch Biopartners Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Arch Biopartners Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Arch Biopartners (TSXV:ARCH) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Arch Biopartners Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

ACHFF:USA

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.